Breast cancer metastasis: markers and models
The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Breast cancer starts as a local disease, but it can metastasize to the lymph nodes and distant organs. At primary diagnosis, prognostic markers are used to assess whether the transition to systemic disease is likely to have occurred. The prevailing model of metastasis reflects this view--it suggests that metastatic capacity is a late, acquired event in tumorigenesis. Others have proposed the idea that breast cancer is intrinsically a systemic disease. New molecular technologies, such as DNA microarrays, support the idea that metastatic capacity might be an inherent feature of breast tumours. These data have important implications for prognosis prediction and our understanding of metastasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immune cells were shown to both enhance and inhibit malignant cells proliferation, migration, and metastasis [125-128].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [125]
In the citing paper
“Chemical gradients play an important role in tumor cell invasion of metastatic cancer [195,196] as it significantly directs the migration and differentiation of tumor cells.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [196]
In the citing paper
“Metastasis is the leading cause of death from breast cancer1, 37-39.”
From Liposomal Formulation of HIF-1α Inhibitor Echinomycin Eliminates Established Metastases of Triple-negative Breast Cancer (2020) · cites this paper as [1]
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760 · cited 1×
“ERBB2 is overexpressed due to gene amplification in 15–30% of human breast cancer”
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Research works printed but not linked: 2
- Fidler, I. J. Metastasis: quantitative analysis of distribution and fate of tumour embolilabeled with 125 I-5-iodo-2′-deoxyuridine. J. Natl Cancer Inst. 45, 773–782 (1970).
- Leighton, J. Inherent malignancy of cancer cells possibly limited by genetically differing cells in the same tumour. Acta Cytol. 9, 138–140 (1965).
Cited by
Items 301–400 of 1,003
The role of osteoclasts in breast cancer bone metastasis
Pape, F. L., Vargas, G., & Clézardin, P. (2016) · Journal of bone oncology · doi:10.1016/j.jbo.2016.02.008 · Cited by 93
Metastasis suppressors: functional pathways
Khan, I., & Steeg, P. S. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.104 · Cited by 104
Lee, Y., Huang, C., Shih, C.-C., & Chang, R. (2020) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2020.104206 · Cited by 93
Evaluating distant metastases in breast cancer: from biology to outcomes
Rabbani, S. A., & Mazar, A. P. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9085-8 · Cited by 104
Change in the microenvironment of breast cancer studied by FTIR imaging
Kumar, S., Desmedt, C., Larsimont, D., Sotiriou, C., & Goormaghtigh, E. (2013) · The Analyst · doi:10.1039/c3an00241a · Cited by 100
Nanni, P., Nicoletti, G., Palladini, A., Croci, S., Murgo, A., Ianzano, M. L., Grosso, V., Stivani, V., Antognoli, A., Lamolinara, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039626 · Cited by 93
“Furthermore, while the general pattern of metastatic spread is known [1,4], the specific organ tropism of individual cancers is unpredictable.”
Leung, E., Xue, A., Wang, Y., Rougerie, P., Sharma, V. P., Eddy, R., Cox, D., & Condeelis, J. (2017) · Oncogene · doi:10.1038/onc.2016.421 · Cited by 93
SNHG5 Promotes Breast Cancer Proliferation by Sponging the miR-154-5p/PCNA Axis
Chi, J.-R., Yu, Z.-H., Liu, B.-W., Zhang, D., Ge, J., Yu, Y., & Cao, X.-C. (2019) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2019.05.013 · Cited by 92
Zhao, H., Liu, C., Gu, Z., Dong, L., Li, F., Yao, C., & Yang, D. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b03755 · Cited by 92
Surgical Injury Enhances the Expression of Genes That Mediate Breast Cancer Metastasis to the Lung
Al-Sahaf, O., Wang, J. H., Browne, T. J., Cotter, T. G., & Redmond, H. P. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181efc635 · Cited by 97
Zhao, Y., Detering, L., Sultan, D. H., Cooper, M. L., You, M., Cho, S., Meier, S. L., Luehmann, H. P., Sun, G., Rettig, M. P., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b01326 · Cited by 94
Metastasis-Entrained Eosinophils Enhance Lymphocyte-Mediated Antitumor Immunity
Grisaru‐Tal, S., Dulberg, S., Beck, L., Zhang, C., Itan, M., Hediyeh-zadeh, S., Caldwell, J. M., Rozenberg, P., Dolitzky, A., Avlas, S., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0839 · Cited by 96
López-González, L., Cendra, A. S., Cendra, C. S., Cervantes, E. D. R., Espinosa, J. C., Pekarek, T., Fraile‐Μartinez, O., Montero, C. G., Rodriguez-Slocker, A. M., Jiménez-Álvarez, L., et al. (2024) · Medicina · doi:10.3390/medicina60010168 · Cited by 107
“For instance, a study by Cheang et al. revealed that Luminal B tumors exhibited a higher Ki67 index and were associated with poorer recurrence-free survival compared to Luminal A tumors [33].”
ResultRiahi, R., Gogoi, P., Sepehri, S., Zhou, Y., Handique, K., Godsey, J., & Wang, Y. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2353 · Cited by 91
Identification of EDIL3 on extracellular vesicles involved in breast cancer cell invasion
Lee, J., Moon, P., Cho, Y., Kim, Y., Kim, I., Park, H.-Y., & Baek, M. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.10.005 · Cited by 96
Targeting of CCBE1 by miR-330-3p in human breast cancer promotes metastasis
Mesci, A., Huang, X., Taeb, S., Jahangiri, S., Kim, Y., Fokas, E., Bruce, J., Leong, H. S., & Liu, S. K. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.105 · Cited by 90
Xu, G., Tan, Y., Xu, T., Yin, D., Wang, M., Shen, M., Chen, X., Shi, X., & Zhu, X. (2017) · Biomaterials Science · doi:10.1039/c6bm00933f · Cited by 90
Studying the influence of angiogenesis in in vitro cancer model systems
Roudsari, L. C., & West, J. L. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.004 · Cited by 97
Kabała‐Dzik, A., Rzepecka‐Stojko, A., Kubina, R., Jastrzȩbska-Stojko, Ż., Stojko, R., Wojtyczka, R. D., & Stojko, J. (2017) · Molecules · doi:10.3390/molecules22091554 · Cited by 89
Endothelial miR-30c suppresses tumor growth via inhibition of TGF-β–induced Serpine1
McCann, J. V., Xiao, L., Kim, D. J., Khan, O. F., Kowalski, P. S., Anderson, D. G., Pecot, C. V., Azam, S. H., Parker, J. S., Tsai, Y., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci123106 · Cited by 100
Zhou, X., Liu, Y., You, J., Zhang, H., Zhang, X., & Ye, L. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.05.028 · Cited by 88
Bourgeois‐Daigneault, M., St-Germain, L. E., Roy, D. G., Pelin, A., Aitken, A. S., Arulanandam, R., Falls, T. J., Garcia, V., Diallo, J., & Bell, J. C. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0744-y · Cited by 88
Li, H., Wang, K., Yang, X., Zhou, Y., Ping, Q., Oupický, D., & Sun, M. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.01.070 · Cited by 88
Mouse models for breast cancer metastasis
Kim, I. S., & Baek, S. H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.070 · Cited by 97
Whole-Cell Impedance Analysis for Highly and Poorly Metastatic Cancer Cells
Cho, Y., Kim, H. S., Frazier, A. B., Chen, Z. G., Shin, D. M., & Han, A. (2009) · Journal of Microelectromechanical Systems · doi:10.1109/jmems.2009.2021821 · Cited by 88
Willis, A. L., Tran, N. L., Chatigny, J. M., Charlton, N., Vu, H., Brown, S. A. N., Black, M. A., McDonough, W. S., Ensign, S. P. F., Niska, J. R., et al. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0005 · Cited by 87
“responsible for the majority of breast cancer deaths (1).”
BackgroundPierozan, P., Cattani, D., & Karlsson, O. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02848-6 · Cited by 89
Active Roles of Tumor Stroma in Breast Cancer Metastasis
Khamis, Z. I., Sahab, Z. J., & Sang, Q.-X. A. (2012) · International Journal of Breast Cancer · doi:10.1155/2012/574025 · Cited by 86
Lipocalin 2 promotes lung metastasis of murine breast cancer cells
Shi, H., Gu, Y., Yang, J., Xu, L., Mi, W., & Yu, W. (2008) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-27-83 · Cited by 87
Howe, E. N., Cochrane, D. R., Cittelly, D. M., & Richer, J. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049987 · Cited by 95
“cancer has improved, it remains the second most deadly cancer for American women, with mortality largely attributed to metastatic disease [2].”
BackgroundXiong, H., Zuo, H., Yan, Y., Occhialini, G., Zhou, K., Wan, Y., & Siegwart, D. J. (2017) · Advanced Materials · doi:10.1002/adma.201700131 · Cited by 87
Michaelidou, K., Tzovaras, A. A., Missitzis, I. L., Ardavanis, A. S., & Scorilas, A. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1860 · Cited by 96
Silencing of GM3 synthase suppresses lung metastasis of murine breast cancer cells
Gu, Y., Zhang, J., Mi, W., Yang, J., Han, F., Lu, X., & Yu, W. (2008) · Breast Cancer Research · doi:10.1186/bcr1841 · Cited by 86
Mitchell, M. J., & King, M. R. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00285.2013 · Cited by 102
Pon, C. K., Lane, J. R., Sloan, E. K., & Halls, M. L. (2015) · The FASEB Journal · doi:10.1096/fj.15-277798 · Cited by 93
Campos, A. V., Salomón, C., Bustos, R., Díaz, J., Martínez, S., Silva, V., Reyes, C., Díaz‐Valdivia, N., Varas‐Godoy, M., Lobos‐González, L., et al. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0094 · Cited by 91
Rationally Designed Ruthenium Complexes for Breast Cancer Therapy
Golbaghi, G., & Castonguay, A. (2020) · Molecules · doi:10.3390/molecules25020265 · Cited by 94
Serum Overexpression of MicroRNA-10b in Patients with Bone Metastatic Primary Breast Cancer
Zhao, F.-L., Hu, G.-D., Wang, X., Zhang, X.-H., Zhang, Y.-K., & Yu, Z.-S. (2012) · Journal of International Medical Research · doi:10.1177/147323001204000304 · Cited by 85
MicroRNAs in breast cancer initiation and progression
Liu, H. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1128-9 · Cited by 87
Huo, D., Clayton, W., Yoshimatsu, T. F., Chen, J., & Olopade, O. I. (2016) · Oncotarget · doi:10.18632/oncotarget.10485 · Cited by 90
“…event in tumorigenesis, (b) the model that the ability to metastasize is an early, inherent property of the breast tumors, (c) the model that metastasis is a mechanical, random process, and (d) the model that tumor DNA in circulating plasma transfects to susceptible cells in distant organs [42].”
Cevatemre, B., Erkısa, M., Aztopal, N., Karakaş, D., Alper, P., Tsimplouli, C., Sereti, E., DIMAS, K. S., Armutak, E. İ., Gürevin, E. G., et al. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.11.027 · Cited by 87
Nguyen, C. C., Baskaran, K., Pupulin, A., Ruvinov, I., Zaitoon, O., Grewal, S. S., Scaria, B., Mehaidli, A., Vegh, C., & Pandey, S. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2505-9 · Cited by 93
Research progress on tumor hypoxia-associative nanomedicine
Xu, X., Chen, S., Yi, N.-B., Li, X., Chen, S., Lei, Z., Cheng, D., & Sun, T. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.003 · Cited by 87
Fu, X., Giretti, M. S., Baldacci, C., Garibaldi, S., Flamini, M. I., Sanchez, A. M., Gadducci, A., Genazzani, A. R., & Simoncini, T. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002790 · Cited by 89
“Cancer cells spread locally and metastasize to distant organs and these processes represent the chief cause of morbidity and death [6].”
Distinguishing mechanisms underlying EMT tristability
Jia, D., Jolly, M. K., Tripathi, S. C., den Hollander, P., Huang, B., Lu, M., Çeliktaş, M., Ramirez‐Peña, E., Ben‐Jacob, E., Onuchic, J. N., et al. (2017) · Cancer Convergence · doi:10.1186/s41236-017-0005-8 · Cited by 90
Calcium transport and signaling in the mammary gland: Targets for breast cancer
Lee, W. J., Monteith, G. R., & Roberts‐Thomson, S. J. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.12.001 · Cited by 85
Grottke, A., Ewald, F., Lange, T., Nörz, D. S., Herzberger, C., Bach, J., Grabinski, N., Gräser, L., Höppner, F., Nashan, B., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146370 · Cited by 91
miR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF-α
Xing, F., Sharma, S., Liu, Y., Mo, Y.-Y., Wu, K., Zhang, Y., Pochampally, R. R., Martinez, L. A., Lo, H., & Watabe, K. (2015) · Oncogene · doi:10.1038/onc.2014.412 · Cited by 92
Yang, M. H., Ma, B., Shao, H., Clark, A. M., & Wells, A. H. (2016) · BMC Cancer · doi:10.1186/s12885-016-2411-1 · Cited by 94
“mortality in breast cancer patients [1, 2].”
YAP and β-Catenin Cooperate to Drive Oncogenesis in Basal Breast Cancer
Quinn, H. M., Vogel, R., Popp, O., Mertins, P., Lan, L., Messerschmidt, C., Landshammer, A., Lisek, K., Château‐Joubert, S., Marangoni, E., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2801 · Cited by 87
Radiolabeled cyclic RGD peptides as radiotracers for tumor imaging
Shi, J., Wang, F., & Liu, S. (2016) · Biophysics Reports · doi:10.1007/s41048-016-0021-8 · Cited by 84
Jiang, K., Song, X., Yang, L., Li, L., Wan, Z., Sun, X., Gong, T., Lin, Q., & Zhang, Z. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.026 · Cited by 90
“Breast cancer primarily metastases to lung, bone and liver [4].”
BackgroundBlockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer
Ireland, L., Santos, A., Campbell, F., Figueiredo, C. R., Hammond, D. E., Ellies, L. G., Weyer-Czernilofsky, U., Bogenrieder, T., Schmid, M. C., & Mielgo, A. (2018) · Oncogene · doi:10.1038/s41388-017-0115-x · Cited by 86
Wang, N., Wang, Q., Tang, H., Zhang, F., Zheng, Y., Wang, S., Zhang, J. C., Wang, Z., & Xie, X. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0635-9 · Cited by 82
Tumour acidosis evaluated in vivo by MRI-CEST pH imaging reveals breast cancer metastatic potential
Anemone, A., Consolino, L., Conti, L., Irrera, P., Hsu, M. Y., Villano, D., Dastrù, W., Porporato, P. E., Cavallo, F., & Longo, D. L. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01173-0 · Cited by 89
Zhou, Q., Gui, S., Zhou, Q., & Wang, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101132 · Cited by 82
Jiang, Q., Pan, Y., Cheng, Y., Li, H., Liu, D., & Li, H. (2016) · Oncology Reports · doi:10.3892/or.2016.4798 · Cited by 82
Mechanism of metastasis suppression by luteolin in breast cancer
Cook, M. T. (2018) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s144202 · Cited by 96
“These therapies have exceptional outcomes for breast cancer patients with confined primary tumors; however, metastatic cancer, being systemic in nature and resistant to chemotherapeutics, tends to have poorer prognosis.(6) This article addresses the aptitude of luteolin (2-[3,4-fihydroxyphenyl]-5,7-dihydroxy-4-chromen…”
Rodriguez, D. A., Ramkairsingh, M., Lin, X., Kapoor, A., Major, P. P., & Tang, D. (2019) · Cancers · doi:10.3390/cancers11071028 · Cited by 85
He, M., Guo, S., & Li, Z. (2015) · Scientific Reports · doi:10.1038/srep11298 · Cited by 84
Legendre, C., Gooden, G. C., Johnson, K., Martinez, R. A., Liang, W. S., & Salhia, B. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0135-8 · Cited by 79
Cancer stem cells, tumor dormancy, and metastasis
Patel, P. R., & Chen, E. I. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00125 · Cited by 84
Blood-based protein biomarkers in breast cancer
Núñez, C. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.12.028 · Cited by 81
Toward the broad adoption of 3D tumor models in the cancer drug pipeline
Cox, M. C., Reese, L. M., Bickford, L. R., & Verbridge, S. S. (2015) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5b00172 · Cited by 80
Human Neural Stem Cell Tropism to Metastatic Breast Cancer
Zhao, D., Najbauer, J., Annala, A. J., Garcia, E. P., Metz, M. Z., Gutova, M., Polewski, M. D., Gilchrist, M., Glackin, C. A., Kim, S. U., et al. (2011) · Stem Cells · doi:10.1002/stem.784 · Cited by 80
Hughes, L., Malone, C., Chumsri, S., Burger, A. M., & McDonnell, S. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9169-z · Cited by 80
“Recent gene expression studies suggest that the formation of distant metastases may be due to the presence of cells within the primary tumour which have the ability to form metastases very early in the disease process [15].”
Benlimame, N., Alaoui-Jamali, M., & Davis, M. B. (2009) · Cited by 80
Yang, J., Jia, Z., Zhang, J., Pan, X., Wei, Y., Ma, S., Yang, N., Liu, Z., & Shen, Q. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202102799 · Cited by 81
Impact of Heat-Shock Protein 90 on Cancer Metastasis
Tsutsumi, S., Beebe, K., & Neckers, L. (2009) · Future Oncology · doi:10.2217/fon.09.30 · Cited by 78
Myeloid cells in circulation and tumor microenvironment of breast cancer patients
Toor, S. M., Khaja, A. S. S., Salhat, H. E., Faour, I., Kanbar, J., Quadri, A., Mohamed, A., & Elkord, E. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-017-1977-z · Cited by 80
The role of miR-100 in regulating apoptosis of breast cancer cells
Gong, Y., He, T., Yang, L., Yang, G., Chen, Y., & Zhang, X. (2015) · Scientific Reports · doi:10.1038/srep11650 · Cited by 82
Breast cancer special types: why bother?
Reis‐Filho, J., & Lakhani, S. R. (2008) · The Journal of Pathology · doi:10.1002/path.2419 · Cited by 78
The theoretical basis of cancer‐stem‐cell‐based therapeutics of cancer: can it be put into practice?
Sánchez-García, I., Vicente‐Dueñas, C., & Cobaleda, C. (2007) · BioEssays · doi:10.1002/bies.20679 · Cited by 87
Xu, Q., Wang, L., Li, H., Han, Q., LI, J., Qu, X., HUANG, S. H., & Zhao, R. C. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1541 · Cited by 83
“Breast cancer, which starts as a local disease and can metastasize to distant organs, is the second leading cause of cancer-related mortality in women (1,2).”
BackgroundRing, B. Z., Hout, D. R., Morris, S. W., Lawrence, K. D., Schweitzer, B. L., Bailey, D. B., Lehmann, B. D., Pietenpol, J. A., & Seitz, R. S. (2016) · BMC Cancer · doi:10.1186/s12885-016-2198-0 · Cited by 86
Biological Functions Driven by mRNAs Carried by Extracellular Vesicles in Cancer
Prieto‐Vila, M., Yoshioka, Y., & Ochiya, T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.620498 · Cited by 83
Noratto, G. D., Porter, W. W., Byrne, D., & Cisneros‐Zevallos, L. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.03.001 · Cited by 84
Lang, J. E., Tereffe, W., Mitchell, M. P., Rao, R., Feng, L., Meric‐Bernstam, F., Bedrosian, I., Kuerer, H. M., Hunt, K. K., Hortobágyi, G. N., et al. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2844-y · Cited by 77
Torres, E. T. R., Goswami, S., Balsamo, M., Wang, Y., Stobezki, R., Adler, E. H., Robinson, B. D., Jones, J. G., Gertler, F. B., Condeelis, J. S., et al. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9388-6 · Cited by 77
“Since about 10–15% of patients develop metastatic disease within 3 years of diagnosis [4, 5] we would expect about five cases from our cohort of 40 to be metastatic within the same time frame.”
Pérez-Yépez, E. A., Ayala‐Sumuano, J., Lezama, R. A., & Meza, I. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.08.015 · Cited by 81
Xie, H.-Y., Shao, Z., & Li, D. (2017) · 癌症:英文版 · doi:10.1186/s40880-017-0202-y · Cited by 79
“Metastasis is a continuous and multi-step biological process, in which a subpopulation of cancer cells with highly invasive and metastatic potential depart from their original locations, degrade the extracellular matrix (ECM), intravasate into the blood or lymphatic vessels, survive in the circulation, and extravasate…”
BackgroundBone Metastases: Molecular Mechanisms and Novel Therapeutic Interventions
Papachristou, D. J., Basdra, E. K., & Papavassiliou, A. G. (2010) · Medicinal Research Reviews · doi:10.1002/med.20224 · Cited by 81
“Via interactions with tumor microenvironment the breast cancer stem cells acquire an additional genetic ‘‘tool box’’ that defines their site of metastasis.(97,98) In addition to the gene signature recent studies suggest that cancer stem cells may also have a microRNA signature that defines their metastatic potential a…”
BackgroundExpression of protein elongation factor eEF1A2 predicts favorable outcome in breast cancer
Kulkarni, G., Turbin, D. A., Amiri, A., Jeganathan, S., Andrade-Navarro, M. A., Wu, T. D., Huntsman, D. D., & Lee, J. M. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9315-8 · Cited by 76
An aptamer ligand based liposomal nanocarrier system that targets tumor endothelial cells
Ara, M. N., Matsuda, T., Hyodo, M., Sakurai, Y., Hatakeyama, H., Ohga, N., Hida, K., & Harashima, H. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.087 · Cited by 79
“Chemotherapy of cancer metastases, which are effective in some patients, are often 112 associated with significant toxicity, due to the nonspecific distribution of cytotoxic drugs 113 which limits the maximum allowable dose [28, 29].”
BackgroundZheng, Y., Ji, S., Czerwiński, A. A., Valenzuela, F., Pennington, M. W., & Liu, S. (2014) · Bioconjugate Chemistry · doi:10.1021/bc500452y · Cited by 76
Bailey‐Downs, L. C., Thorpe, J. E., Disch, B. C., Bastian, A., Hauser, P. J., Farasyn, T., Berry, W. L., Hurst, R. E., & Ihnat, M. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098624 · Cited by 81
“recurrence at the site of the primary tumor [1].”
Backgroundde Carvalho, A. L. M. B., Pilling, M. J., Gardner, P., Doherty, J., Cinque, G., Wehbe, K., Kelley, C. S., de Carvalho, L. A. E. B., & Marques, M. P. M. (2016) · Faraday Discussions · doi:10.1039/c5fd00148j · Cited by 80
Periostin is identified as a putative metastatic marker in breast cancer-derived exosomes
Vardaki, I., Ceder, S., Rutishauser, D., Baltatzis, G., Foukakis, T., & Panaretakis, T. (2016) · Oncotarget · doi:10.18632/oncotarget.11663 · Cited by 79
“Current prognostic factors in breast cancer include tumor characteristics such as tumor size, the status of axillary lymph nodes and grade, as well as immunohistochemistrybased tumor markers such as the estrogen receptor (ER), progesterone receptor (PgR), the proliferation marker Ki67 and ERBB2 expression [2, 4-9].”
CXCR4-Targeted and Redox Responsive Dextrin Nanogel for Metastatic Breast Cancer Therapy
Zhang, F., Gong, S., Wu, J., Li, H., Oupický, D., & Sun, M. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b00208 · Cited by 76
Regan, D. P., Coy, J. W., Chahal, K. K., Chow, L., Kurihara, J. N., Guth, A. M., Kufareva, I., & Dow, S. W. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800619 · Cited by 73
Shu, C., Zha, H., Long, H., Wang, X., Yang, F., Gao, J., Hu, C., Zhou, L. Q., Guo, B., & Zhu, B. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1515-2 · Cited by 81
Chen, W. J., Tsai, J., Hsu, L., Lin, C., Hong, H.-M., & Pan, M. (2021) · Journal of Food and Drug Analysis · doi:10.38212/2224-6614.3090 · Cited by 75
“focused on targeting primary breast tumor [39];”
Huang, D., Wu, T. S., Lan, S., Liu, C., Guo, Z., & Zhang, W. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121808 · Cited by 76
Tailoring the Amphiphilic Structure of Zwitterionic AIE Photosensitizers to Boost Antitumor Immunity
Zhang, T., Yang, X. W., Ou, X., Lee, M. M. S., Zhang, J., Xu, C., Yu, X., Gong, P., Lam, J. W. Y., Zhang, P., et al. (2023) · Advanced Materials · doi:10.1002/adma.202303186 · Cited by 79
Du, J., Wang, X., Zhou, Q., ZHANG, T.-L., Lu, Y.-Y., Zhang, H., & Su, S.-B. (2013) · Oncology Reports · doi:10.3892/or.2013.2498 · Cited by 75
Xu, S., Yan, P.-J., & Shao, Z.-M. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0812-0 · Cited by 79
Alexopoulou, A. N., Leao, M., Caballero, O. L., Silva, L. M. D., Reid, L., Lakhani, S. R., Simpson, A. J. G., Marshall, J. F., Neville, A. M., & Jat, P. (2010) · Breast Cancer Research · doi:10.1186/bcr2610 · Cited by 77
Recent Advances in Discovering the Role of CCL5 in Metastatic Breast Cancer
Khalid, A., Wolfram, J., Ferrari, I., Mu, C., Mai, J., Yang, Z., Zhao, Y., Ferrari, M., Ma, X., & Shen, H. (2015) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955751513150923094709 · Cited by 81
Gebremeskel, S., Clattenburg, D. R., Slauenwhite, D., Lobert, L. M., & Johnston, B. (2015) · OncoImmunology · doi:10.1080/2162402x.2014.995562 · Cited by 79
YBX1 gene silencing inhibits migratory and invasive potential via CORO1C in breast cancer in vitro
Lim, J. P., Shyamasundar, S., Gunaratne, J., Scully, O. J., Matsumoto, K., & Bay, B. (2017) · BMC Cancer · doi:10.1186/s12885-017-3187-7 · Cited by 81
Metadata
- Authors
- Weigelt, B., Peterse, J. L., & van't Veer, L. J.
- Affiliations
- The Netherlands Cancer Institute (NL)
- ORCID
- Weigelt, Britta
- Venue
- Nature Reviews Cancer
- Published
- 2005-08-01
- Volume
- 5
- Issue
- 8
- Pages
- 591-602
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2004280628
- Semantic Scholar
- 3bd1490d7b6c8daa59bd35260c6c71e39d3d62fa
- Cited by
- 2,232
- References
- 112
- Citations by year
- 2026: 34 · 2025: 69 · 2024: 90 · 2023: 111 · 2022: 139 · 2021: 154 · 2020: 159 · 2019: 147 · 2018: 140 · 2017: 191 · 2016: 162 · 2015: 152 · 2014: 121 · 2013: 104 · 2012: 88
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- breast cancer, metastasis, prognostic factors, metastatic potential, lymph node metastasis, distant metastasis, carcinogenesis, DNA microarrays, systemic disease, metastasis model
- MeSH terms
- Breast Neoplasms, Female, Humans, Neoplasm Metastasis, Biomarkers, Tumor, Models, Animal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.